Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04059250 · ClinicalTrials.gov registry record · NA
Nobio Clinical Study - Demineralization Prevention With a New Antibacterial Restorative Composite
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04059250 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 25 participants.
The verdict
NCT04059250, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Nobio has developed dental restorative materials with long term antibacterial properties in order to fight recurrent decay/caries around restorations. These composites with incorporated non-leaching antibacterial agents might overcome the vicious circle of newly developed cavities around freshly placed fillings. The investigators will ask lower partial denture wearers to allow them to place a "gap model" with the Nobio-composite and enamel slab in one denture flange. In the other denture flange a gap model with a standard composite will be placed as control. In the laboratory the investigators will test with established methods for demineralization/caries prevention in the test and control enamel slabs, respectively.
Interventions
- DEVICE Nobio composite
- DEVICE traditional composite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2020-03-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04059250
The ClinicalTrials.gov registry entry for NCT04059250 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nobio composite is the first listed.
NCT04059250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04059250 about?
NCT04059250 is a clinical study titled "Nobio Clinical Study - Demineralization Prevention With a New Antibacterial Restorative Composite". Nobio has developed dental restorative materials with long term antibacterial properties in order to fight recurrent decay/caries around restorations. These composites with incorporated non-leaching antibacterial agents might overcome the vicious circle of newly developed cavities around freshly pla...
What is the current status of trial NCT04059250?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-05-28. Estimated completion is 2020-03-10.
What interventions are being tested in trial NCT04059250?
The interventions under investigation include: Nobio composite (DEVICE), traditional composite (DEVICE).
Who is sponsoring clinical trial NCT04059250?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.